# Cocaine Opioid Oxytocin Option - Limited

> **NCT02028533** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 30 (actual)

## Conditions studied

- Opioid Use Disorder
- Cocaine Use Disorder

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02028533
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02028533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02028533, "Cocaine Opioid Oxytocin Option - Limited". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02028533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*